Skip to main content
Caplight Logo









Messenger Bio

Messenger Bio

Private
MelbourneHealthcare & Life Scienceshttps://www.messenger.bio/

Last Round

Grant

Sep 6, 2024

Total Funding Raised

$666,600

Company Overview

Messenger Bio is a biotechnology company that provides customized mRNA synthesis reagents, lipid nanoparticle (LNP) formulation services, and preclinical testing services for research applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

mRNA synthesisLNP formulationlipid nanoparticleCRMOcontract research organizationpreclinical testingmRNA drug discoverytransfection reagentsbiotech servicesmRNA designcodon optimizationbiotech outsourcinglab-on-demanddrug development services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Messenger Bio Comparables

Compare Messenger Bio with similar companies based on industry and business-model similarity.

Messenger Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vernal Biosciences
82%
eTheRNA
75%
Danaher Corporation
75%

Messenger Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 6, 2024
GrantJun 1, 2023
AcceleratorNov 18, 2022

Messenger Bio Investors

Notable investors and investment history

Messenger Bio investors
InvestorRounds
mRNA VictoriaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 89% MoM, reaching 4.3K.

  • Nov 11, 2025

    Monthly visitors increased 66% MoM.

Messenger Bio Filings

Explore SEC and related filing metadata, where available.

Messenger Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Messenger Bio's valuation, stock price, and market status.

Is Messenger Bio a public or private company?

Messenger Bio is a private company.

What is the current stock price of Messenger Bio?

Messenger Bio is a private company with no public stock price. Caplight tracks Messenger Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Messenger Bio worth (valuation)?

Valuation information for Messenger Bio is not publicly available.

Can I buy Messenger Bio stock?

Messenger Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Messenger Bio's last funding round?

Messenger Bio's most recent funding round was Grant on September 6, 2024.

Who are the main investors in Messenger Bio?

Key investors in Messenger Bio include mRNA Victoria.

Will Messenger Bio IPO soon?

No public IPO plans have been announced for Messenger Bio.

How can I track Messenger Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Messenger Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMelbourne
Employee Range4
Year Founded2021
Last FundingSep 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?